Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides (Q30667754)

26 June 2017

Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides (English)

1 reference

26 June 2017

0 references

Mohan N

1

1 reference

26 June 2017

Edwards ET

2

1 reference

26 June 2017

Cupps TR

3

1 reference

26 June 2017

Oliverio PJ

4

1 reference

26 June 2017

Sandberg G

5

1 reference

26 June 2017

Crayton H

6

1 reference

26 June 2017

Richert JR

7

1 reference

26 June 2017

Siegel JN

8

1 reference

26 June 2017

1 December 2001

1 reference

26 June 2017

Arthritis & Rheumatology

1 reference

26 June 2017

44

1 reference

26 June 2017

12

1 reference

26 June 2017

2862-2869

1 reference

The pathophysiology of tumor necrosis factors

26 June 2017

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2862%3A%3AAID-ART474%3E3.0.CO%3B2-W

Two tumour necrosis factor receptors: structure and function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2862%3A%3AAID-ART474%3E3.0.CO%3B2-W

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2862%3A%3AAID-ART474%3E3.0.CO%3B2-W

Anti?tumor necrosis factor therapy abrogates autoimmune demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2862%3A%3AAID-ART474%3E3.0.CO%3B2-W

Tumor necrosis factor identified in multiple sclerosis brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2862%3A%3AAID-ART474%3E3.0.CO%3B2-W

Association between Tumor Necrosis Factor-α and Disease Progression in Patients with Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2862%3A%3AAID-ART474%3E3.0.CO%3B2-W

Approaches for identifying and defining environmentally associated rheumatic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2862%3A%3AAID-ART474%3E3.0.CO%3B2-W

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2862%3A%3AAID-ART474%3E3.0.CO%3B2-W

On the role of tumor necrosis factor and receptors in models of multiorgan failure, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2862%3A%3AAID-ART474%3E3.0.CO%3B2-W

Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2862%3A%3AAID-ART474%3E3.0.CO%3B2-W

Interferon-beta1A-induced polyarthritis in a patient with the HLA-DRB1*0404 allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2862%3A%3AAID-ART474%3E3.0.CO%3B2-W

Evidence for common autoimmune disease genes controlling onset, severity, and chronicity based on experimental models for multiple sclerosis and rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2862%3A%3AAID-ART474%3E3.0.CO%3B2-W

Experimental autoimmune encephalomyelitis: immunotherapy with anti-tumor necrosis factor antibodies and soluble tumor necrosis factor receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2862%3A%3AAID-ART474%3E3.0.CO%3B2-W

TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2862%3A%3AAID-ART474%3E3.0.CO%3B2-W

A critical role of the p75 tumor necrosis factor receptor (p75TNF-R) in organ inflammation independent of TNF, lymphotoxin alpha, or the p55TNF-R.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2862%3A%3AAID-ART474%3E3.0.CO%3B2-W

Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice: models for multiple sclerosis with primary oligodendrogliopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2862%3A%3AAID-ART474%3E3.0.CO%3B2-W

Autoimmune diseases in families of French patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2862%3A%3AAID-ART474%3E3.0.CO%3B2-W

10.1002/1529-0131(200112)44:12<2862::AID-ART474>3.0.CO;2-W

21 January 2018

Identifiers

DOI

1 reference

26 June 2017

1 reference